NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Isoprostane and isofuran lipid mediators accumulate in stored red blood cells and influence platelet function in vitro.

Author(s): Spinelli SL, Lannan KL, Casey AE, Croasdell A, Curran TM, Henrichs KF, Pollock SJ, Milne GA, Refaai MA, Francis CW, Phipps RP, Blumberg N

Publication: Transfusion, 2014, Vol. 54, Page 1569-79

PubMed ID: 24192515 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of red blood cell (RBC) leukoreduction and storage duration on the accumulation of F2-isoprostanes (F2-IsoPs) and isofurans (IsoFs) and on platelet (plt) function.

Conclusion of Paper

During refrigerated storage of non-leukoreduced RBCs, soluble CD40 ligand (sCD40L) levels increased. Storage of leukoreduced RBCs increased the levels of F2-IsoPs, IsoFs and hemoglobin and increased the RBC supernatant's ability to activate plts as determined by thromboxane B2 (TXB2) and sCD40L release and CD62P expression (non-leukoreduced RBCs were not evaluated). Leukoreduction increased levels of Thromboxane B2 (TXB2) and prostaglandin E2 (PGE2), and decreased levels of sCD40L in RBCs, but significance depended on storage duration. Supernatants of refrigerated non-leukoreduced RBCs induced more plt aggregation than the supernatants of fresh RBCs, but the supernatants of refrigerated leukoreduced RBCs induced comparable aggregation to fresh RBCs. Washing RBCs after storage reduced F2-IsoPs and IsoFs levels, and while levels increased during the 24 h post wash storage, they remained significantly lower than pre-wash levels.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of RBC leukoreduction and storage duration on the accumulation of F2-IsoPs and IsoFs and on plt function. Additive solution 1 (AS-1) RBCs were obtained from a blood bank and leukoreduced with a leukoreduction filter. RBC supernatants were obtained by centrifugation. Some RBCs were washed after 13 or 26 days of storage in an isotonic solution and then stored for another 24 h at 4 degrees C. Plts were obtained by centrifugation of sodium citrate blood from healthy blood donors and were resuspended in Tyrode's/acid citrate dextrose (ACD) with 0.1 ug/mL prostacyclin. Plt supernatants were stored frozen at -80 degrees C.

    Summary of Findings:

    During refrigerated storage of non-leukoreduced RBCs, sCD40L levels increased. During storage of leukoreduced RBCs, levels of F2-IsoPs, IsoFs and hemoglobin increased linearly (R2=0.9632, R2=0.8816 and R2=0.9936, respectively). Non-leukoreduced RBCs were not evaluated. Further, the ability of leukoreduced RBC supernatants to induce TXB2 and sCD40L release from Plts increased after 19 and 40 days of refrigeration, respectively (p<0.05, both), and CD62P expression on Plts increased after 40 days of refrigerated storage (p<0.05). While increasing the concentration of 8-Iso-PGF led to increased Plt release of TXB2 and expression of CD62P, it did not affect sCD40L release. Leukoreduction increased levels of TXB2 in RBCs stored <8 or >20 days (p<0.05, both), decreased levels of sCD40L in RBCs stored <8 or >20 days (p<0.05, both), and increased PGE2 in RBCs stored for >20 days only (p<0.05). Additionally, the authors report a reduction in vascular endothelial growth factor (VEGF) after leukoreduction of RBCs. Supernatants of non-leukoreduced RBCs refrigerated for <8 or >20 days induced more Plt aggregation than supernatants of fresh RBCs, but the supernatants of leukoreduced refrigerated RBCs induced comparable aggregation to fresh RBCs. Washing RBCs after storage reduced F2-IsoPs and IsoFs (p<0.05 for those stored 13 or 26 days), and while levels increased during the 24 h post wash storage, they remained significantly lower than pre-wash levels (p<0.05 for those stored 13 or 26 days).

    Biospecimens
    Preservative Types
    • Other Preservative
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Small molecule GC-MS
    Cell count/volume Flow cytometry
    Lipid Enzyme assay
    Protein ELISA
    Protein Spectrophotometry
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Storage duration 0 h
    24 h
    5 days
    <8 days
    12 days
    19 days
    >20 days
    26 days
    33 days
    40 days
    47 days
    Biospecimen Aliquots and Components Blood processing method Leukoreduced
    Non-leukoreduced
    Washed
    Not washed
    Analyte Extraction and Purification Washing Washed
    Unwashed
    Biospecimen Preservation Type of fixation/preservation Refrigeration
    Frozen

You Recently Viewed  

News and Announcements

  • 2025’s Most Popular SOPs: See What Users Downloaded Most

  • Improving RNAseq Analysis of Small Biospecimens: New Recommendations Available

  • 2026 NCI Best Practices for Biospecimen Resources is Now Available!

  • More...